MYC and breast neoplasm: Reinforcing this idea of overexpression of c-myc protein in cells that are more differentiated, Le Roy et al.37demonstrated that patients with breast tumor receptors positive for estrogens who received treatment with tamoxifen showed decreased levels of c-myc messenger RNA, in comparison with patients who had not received this drug.